Effectiveness, safety, and composite clinical outcomes of apixaban, dabigatran, rivaroxaban, relative to warfarin in non-valvular atrial fibrillation patients in the US Medicare population
27 August 2018 (08:30 - 12:30)
Organised by:
Abstract
Slides
About the speaker
Bristol-Myers Squibb, Lawrenceville (United States of America)
27 More presentations in this session
Access the full session
The Event
ESC Congress 2018
27 August 2018
08:30 CET
You may be interested in
Congress Session
Congress Session
